Omnimmune Cash from 2010 to 2026

OMMH Stock  USD 0.0001  0.00  0.00%   
Omnimmune Holdings' Cash is increasing with slightly volatile movements from year to year. Cash is predicted to flatten to 6,148. Cash is the total amount of money in the form of currency that Omnimmune Holdings has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-12-31
Previous Quarter
6.5 K
Current Value
6.1 K
Quarterly Volatility
661.34029487
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Omnimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnimmune Holdings' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Omnimmune financial statements analysis is a perfect complement when working with Omnimmune Holdings Valuation or Volatility modules.
  
Build AI portfolio with Omnimmune Stock
Check out the analysis of Omnimmune Holdings Correlation against competitors.
For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.

Latest Omnimmune Holdings' Cash Growth Pattern

Below is the plot of the Cash of Omnimmune Holdings over the last few years. Cash refers to the most liquid asset of Omnimmune Holdings, which is listed under current asset account on Omnimmune Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Omnimmune Holdings customers. The amounts must be unrestricted with restricted cash listed in a different Omnimmune Holdings account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Omnimmune Holdings' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnimmune Holdings' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Omnimmune Cash Regression Statistics

Arithmetic Mean5,562
Geometric Mean5,513
Coefficient Of Variation11.89
Mean Deviation282.61
Median5,627
Standard Deviation661.34
Sample Variance437,371
Range3.3K
R-Value0.56
Mean Square Error321,343
R-Squared0.31
Significance0.02
Slope73.06
Total Sum of Squares7M

Omnimmune Cash History

2026 6147.5
2025 6471.05
2011 5627.0
2010 3160.0

Other Fundumenentals of Omnimmune Holdings

Omnimmune Holdings Cash component correlations

About Omnimmune Holdings Financial Statements

Investors use fundamental indicators, such as Omnimmune Holdings' Cash, to determine how well the company is positioned to perform in the future. Although Omnimmune Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cash6.5 K6.1 K
Change In Cash-42.3 K-40.2 K
Other Cashflows From Financing Activities241.5 K253.6 K
Total Cash From Operating Activities-227.2 K-238.5 K
Total Cash From Financing Activities236.3 K224.4 K
Free Cash Flow Yield(328.24)(344.65)
Operating Cash Flow Per Share(0.03)(0.03)
Free Cash Flow Per Share(0.03)(0.03)
EV To Operating Cash Flow(10.33)(10.85)
EV To Free Cash Flow(10.33)(10.85)
Operating Cash Flow Sales Ratio(143.34)(150.51)
Cash Flow Coverage Ratios(0.11)(0.13)
Cash Flow To Debt Ratio(0.11)(0.13)

Currently Active Assets on Macroaxis

When determining whether Omnimmune Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omnimmune Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omnimmune Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omnimmune Holdings Stock:
Check out the analysis of Omnimmune Holdings Correlation against competitors.
For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnimmune Holdings. If investors know Omnimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnimmune Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(20.76)
The market value of Omnimmune Holdings is measured differently than its book value, which is the value of Omnimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Omnimmune Holdings' value that differs from its market value or its book value, called intrinsic value, which is Omnimmune Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnimmune Holdings' market value can be influenced by many factors that don't directly affect Omnimmune Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnimmune Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnimmune Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.